Oireachtas Debate on Medicinal Products Questions HSE Reimbursement (oireachtas.ie)

• Oireachtas scrutinizes HSE drug reimbursement delays
• Patient access to innovative medicines debated
• Calls for transparency and faster evaluation processes

"The Irish parliament held a debate on medicinal products on March 3, 2026, scrutinizing HSE reimbursement decisions that directly impact drug pricing and patient access. Parliamentarians raised concerns about delays in the assessment process and the resulting barriers for patients, particularly those with rare diseases, calling for greater transparency and faster decision-making."